EBV cancer vaccine (Stemirna Therapeutics)

N/A

Report date: 2025/12/18 17:46:35

Base Information

Drug NameEBV cancer vaccine (Stemirna Therapeutics)
Drug Alias NamemRNA vaccine (Stemirna Therapeutics)mRNA vaccine (Stemirna Therapeutics)
ClassificationVaccines > Development/production technology > Nucleic acid vaccine > RNA vaccineVaccines > Application > Prophylactic vaccine
Mechanisms of ActionImmunomodulators
TargetsNot applicable
Therapy Area/IndicationsStomach NeoplasmsNasopharyngeal CarcinomaLymphoma +[5] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaPreclinical
Originator CompaniesStemirna Therapeutics
China Registration ClassN/A

Develop Information

Active CompaniesStemirna Therapeutics
Inactive CompaniesN/A
Active IndicationsStomach NeoplasmsNasopharyngeal CarcinomaLymphoma +[4] 
Inactive IndicationsNeoplasms

Other Information

ATC CodeN/A
Related LinksN/A